Media Mentions

By examining bacteria’s own primitive immune systems, researchers may have found a way to prevent or slow the development of bacterial drug resistance.

Three scientists who have received support from NIGMS are recognized with the Nobel Prize in chemistry for their work on green fluorescent protein.

Scientists have found a new way to produce stem cell-like cells from mouse liver cells. The new technique sidesteps the cancer-causing potential of a previously developed method.

NIGMS grantees explain sepsis and a treatment strategy that may increase survival from the life-threatening condition.

Advances led by PSI-supported scientists have had a major technological impact on structural genomics efforts. 

In this on-camera interview, the NIGMS Director answers questions about MIDAS and its projects focused on pandemic flu. 

MIDAS-supported researchers describe their efforts to model the spread of a potential pandemic flu. 

Scientists are learning that even small genetic changes can make us more vulnerable to certain diseases or alter our responses to particular medicines.

NIGMS is funding a large, interdisciplinary group of researchers, who are planning to test a wide array of approaches to promote wound healing.

Two teams of scientists, one supported by NIGMS, have turned ordinary human skin cells into what appear to be embryonic stem cells without using eggs or embryos.

The blood thinner warfarin has become the first widely used drug that will include genetic tasting data on its label, moving personalized medicine into the mainstream.

Researchers have found further evidence that normal genetic variations affect how the body responds to medications, but don't expect a DNA test before your next prescription.

NIGMS grantee Susan Lindquist is studying how misshaped proteins can lead to neurodegenerative disorders like Parkinson’s disease.

The article features the emerging field of systems biology and the work of several NIGMS grantees who are at the center of it.

NIGMS grantee Roger D. Kornberg wins the Nobel Prize for revealing the molecular basis of eukaryotic transcription, the process of copying DNA into RNA.

NIGMS grantees Andrew Z. Fire and Craig C. Mello receive the Nobel Prize for their discovery of RNA interference.

NIGMS funds Princeton geneticist Bonnie Bassler, who studies quorum sensing, a chemical strategy bacteria use to join together into organized groups.

NIGMS is funding a researcher who aims to predict which patients will respond well to a class of drugs called thiopurines, which are used to treat inflammatory bowel disease and cancer, among other ailments.

A review of several studies that examine genetic variations and how they influence an individual’s response to particular medications.

The Washington Post featured colorful images generated by NIGMS scientists and previously highlighted in the NIGMS monthly electronic newsletter Biomedical Beat.

Researchers supported by the PSI and the NIGMS Small Business Innovation Research Program have developed a miniature synchrotron that could transform many fields of biomedical research.

Results from the latest NIGMS-supported pandemic flu modeling project, which simulates outbreaks in the United States.